StockWatch
·
Biotechnology: Pharmaceutical Preparations
BuybackJul 30, 2026, 08:32 AM

Lite Strategy Repurchases 4.9M Shares for $5.4M

AI Summary

Lite Strategy, Inc. announced it has repurchased approximately 4.9 million shares of its common stock, or 13% of shares outstanding, for $5.4 million at an average price of $1.11 per share since December 2025 through July 17, 2026. The company funded these repurchases entirely through active treasury operations, leveraging its Litecoin holdings to monetize the discount to Net Asset Value (NAV). This strategy has narrowed the NAV discount from the low 40% range to below 25%, while maintaining a debt-free balance sheet. Lite Strategy also provided preliminary financial estimates for fiscal year 2026, including $5.7 million in cash and $1.1 million in total liabilities.

Key Highlights

  • Repurchased approximately 4.9 million shares of common stock.
  • Deployed $5.4 million at an average price of $1.11 per share.
  • Repurchases represent 13% of shares outstanding at program commencement.
  • Funded repurchases entirely through active treasury operations (Litecoin sales and covered call premiums).
  • NAV discount narrowed from low 40% range to below 25%.
  • Holds 819,070 LTC against 31,882,648 shares outstanding as of July 17, 2026.
  • Preliminary FY2026 cash of $5.7 million and total liabilities of $1.1 million.